Wilmington, Delaware, Sept. 17, 2024 (GLOBE NEWSWIRE) — Allied Market Research published a report, titled, “Adhesion Barrier Market by Type (Synthetic Adhesion Barrier and Natural Adhesion Barrier), Application (General/Abdominal Surgeries, Gynecological Surgeries, Cardiovascular Surgeries, Orthopedic Surgeries, Neurological Surgeries and Other Applications), and End User (Hospitals, Specialty Clinics, and Ambulatory Surgical Centers): Global Opportunity Analysis and Industry Forecast, 2024-2033″. According to the report, the adhesion barrier market was valued at $0.7 billion in 2023, and is estimated to reach $1.5 billion by 2033, growing at a CAGR of 7.8% from 2024 to 2033. 

Request Sample of the Report on Adhesion Barrier Market Forecast 2033 – https://www.alliedmarketresearch.com/request-sample/A09554 

Prime determinants of growth 

Alarming increase in the prevalence of chronic diseases has emerged as a primary driving force behind the expansion of the adhesion barrier market. Notable increase has been witnessed in the incidence of chronic health conditions such as cardiovascular diseases, diabetes, cancer, and gastrointestinal disorders. These conditions often necessitate surgical interventions for treatment, whether for disease management, symptom alleviation, or curative purposes. Moreover, the growing number of surgical procedures performed to address chronic diseases has led to a higher incidence of post-operative complications, including the formation of adhesions. Adhesions, abnormal tissue connections that can develop between internal organs or tissues following surgery, pose significant risks to patient health and can lead to complications such as bowel obstructions, infertility, and chronic pain. 

In response to the heightened awareness of these complications, there has been an increased demand for adhesion prevention products among healthcare providers and surgeons. Adhesion barriers play a crucial role in reducing the likelihood of adhesion formation post surgery, thereby minimizing patient morbidity, improving surgical outcomes, and enhancing the quality of life for individuals with chronic diseases. 

Report coverage & details 

Want to Explore More, Connect to our Analyst – 

https://www.alliedmarketresearch.com/connect-to-analyst/A09554 

Segment Highlights 

The adhesion barrier market is segmented into product type, application, end user, and region. By product type, the market is divided into synthetic adhesion barrier and natural adhesion barrier. Depending on application, it is segregated into general/abdominal surgeries, gynecological surgeries, cardiovascular surgeries, orthopedic surgeries, neurological surgeries, and other applications. On the basis of end user, it is fragmented into hospitals, specialty clinics, and ambulatory surgical centers. 

By product type, the synthetic adhesion barrier segment is expected to dominate market share in 2023, due to the fact that synthetic barriers are engineered to provide a controlled barrier between tissues, effectively preventing adhesion formation without interfering with the body’s natural healing processes. Their standardized composition and manufacturing processes ensure reproducible results, instilling confidence among surgeons and healthcare providers in their efficacy. Depending on application, the general/abdominal surgeries segment was the major shareholder in 2023, due to the fact that general/abdominal surgeries are associated with a higher risk of post-operative adhesion formation compared to surgeries in other body parts. On the basis of end user, the hospital segment acquired the maximum share in 2023. This is attributed to the fact that within hospital settings, a diverse array of surgical procedures is performed across various medical specialties, ranging from routine appendectomies to complex cardiac surgeries. This broad spectrum of surgeries translates to a consistent and substantial demand for adhesion prevention products to mitigate the risk of post-operative complications, including adhesions. Furthermore, hospitals possess the necessary infrastructure, resources, and skilled surgical teams to support the utilization of adhesion barriers effectively. Surgeons, nurses, and operating room staff are trained in the proper application of these products, ensuring their appropriate use during surgical procedures. 

Regional Outlook 

North America holds a significant share of the market, driven by advanced healthcare systems, high adoption rates of innovative medical technologies, and increasing surgical volumes. The presence of key market players and ongoing R&D activities contribute to the region’s dominance. In Europe, stringent regulatory frameworks and emphasis on patient safety propel the adoption of adhesion prevention products, particularly in countries with robust healthcare systems and high healthcare expenditure. 

Asia-Pacific is witnessing rapid growth attributed to expanding healthcare infrastructure, rising prevalence of chronic diseases, and increasing demand for surgical interventions. Latin America and the Middle East & Africa are also experiencing growth driven by rising healthcare expenditure, increasing awareness about adhesion-related complications, and efforts to enhance surgical outcomes. However, the market growth in these regions may be constrained by economic challenges, healthcare disparities, and regulatory hurdles. 

Key Market Players 

• Integra LifeSciences Holdings Corporation 

• Atrium Medical Corporation 

The report provides a detailed analysis of these key players in the global adhesion barrier market. These players have adopted different strategies such as product launch, acquisition, and partnership to increase their market share and maintain dominant shares in different regions. The report is valuable in highlighting business performance, operating segments, product portfolio, and strategic moves of market players to showcase the competitive scenario. 

For Purchase Related Queries/Inquiry – https://www.alliedmarketresearch.com/purchase-enquiry/A09554 

Recent Developments in Adhesion Barrier Market Worldwide 

• In June 2022, CGBIO launched Mediclore, an anti-adhesion agent in Indonesia. Mediclore inhibits adhesion by changing from sol to gel form by body temperature when applied to the body. 

• In January 2021, Integra LifeSciences Holdings Corporation announced the acquisition of the Acell Inc. 

• In October 2021, Toray Industry Inc. entered into a partnership with ASKA Pharmaceuticals Co., Ltd. to develop and commercialize adhesion barrier. Under the agreement, Toray and ASKA will jointly develop the product to obtain a marketing approval of the product in Japan. Upon the approval, Toray will manufacture the product, as ASKA will exclusively market it in Japan. 

Trending Reports in Healthcare Industry:   

Drug Screening Market – Global Opportunity Analysis and Industry Forecast, 2023-2032  

Digital Pathology Market – Global Opportunity Analysis and Industry Forecast, 2023-2032  

Antinuclear Antibody Test Market – Global Opportunity Analysis and Industry Forecast, 2023-2032  

Consumer Healthcare Market – Global Opportunity Analysis and Industry Forecast, 2023-2032 

AVENUE- A Subscription-Based Library (Premium on-demand, subscription-based pricing model) Offered by Allied Market Research: 

AMR introduces its online premium subscription-based library Avenue, designed specifically to offer cost-effective, one-stop solution for enterprises, investors, and universities. With Avenue, subscribers can avail an entire repository of reports on more than 2,000 niche industries and more than 12,000 company profiles. Moreover, users can get an online access to quantitative and qualitative data in PDF and Excel formats along with analyst support, customization, and updated versions of reports. 

Get an access to the library of reports at any time from any device and anywhere. For more details, follow the link: https://www.alliedmarketresearch.com/library-access 

About Allied Market Research: 

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Wilmington, Delaware. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains. AMR offers its services across 11 industry verticals including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverages, Energy & Power, Semiconductor & Electronics, Automotive & Transportation, ICT & Media, Aerospace & Defense, and BFSI. 

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.  

Contact 

David Correa 

1209 Orange Street, 

Corporation Trust Center, 

Wilmington, New Castle, 

Delaware 19801 USA. 

Toll Free: +1-800-792-5285 

Int’l: +1-503-894-6022 

UK: +44-845-528-1300 

Hong Kong: +852-301-84916 

India (Pune): +91-20-66346060 

Fax: +1-855-550-5975 

help@alliedmarketresearch.com   

Web: https://www.alliedmarketresearch.com    

Follow Us on: LinkedIn Twitter